Published in Nat Genet on April 13, 2008
Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. Nat Genet (2009) 4.28
Forging a field: the golden age of iron biology. Blood (2008) 3.83
Hepcidin and iron regulation, 10 years later. Blood (2011) 3.80
The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. Cell Metab (2008) 3.78
Hepcidin and iron homeostasis. Biochim Biophys Acta (2012) 2.96
A genome-wide association study of red blood cell traits using the electronic medical record. PLoS One (2010) 2.59
The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice. J Clin Invest (2011) 2.30
Common variants in TMPRSS6 are associated with iron status and erythrocyte volume. Nat Genet (2009) 2.29
Down-regulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis. Blood (2010) 2.20
Genome-wide association study identifies variants in TMPRSS6 associated with hemoglobin levels. Nat Genet (2009) 2.19
Proinflammatory state, hepcidin, and anemia in older persons. Blood (2010) 2.19
Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels. Am J Hum Genet (2008) 2.01
An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia. Blood (2012) 1.94
β-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism. Blood (2011) 1.81
Type II transmembrane serine proteases. J Biol Chem (2009) 1.77
A genome-wide association analysis of serum iron concentrations. Blood (2009) 1.55
Mechanisms of mammalian iron homeostasis. Biochemistry (2012) 1.51
Unbiased RNAi screen for hepcidin regulators links hepcidin suppression to proliferative Ras/RAF and nutrient-dependent mTOR signaling. Blood (2014) 1.50
Reducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in mice. J Clin Invest (2013) 1.44
Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD. Am J Kidney Dis (2010) 1.43
Iron homeostasis and the inflammatory response. Annu Rev Nutr (2010) 1.40
The long history of iron in the Universe and in health and disease. Biochim Biophys Acta (2011) 1.33
Manipulation of the hepcidin pathway for therapeutic purposes. Haematologica (2013) 1.32
Molecular basis of inherited microcytic anemia due to defects in iron acquisition or heme synthesis. Haematologica (2009) 1.32
The liver: conductor of systemic iron balance. Blood (2013) 1.30
Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis. Haematologica (2009) 1.27
The cutting edge: membrane-anchored serine protease activities in the pericellular microenvironment. Biochem J (2010) 1.27
Membrane-anchored serine proteases in vertebrate cell and developmental biology. Annu Rev Cell Dev Biol (2011) 1.26
Deletion of TMPRSS6 attenuates the phenotype in a mouse model of β-thalassemia. Blood (2012) 1.25
Hemojuvelin-neogenin interaction is required for bone morphogenic protein-4-induced hepcidin expression. J Biol Chem (2009) 1.24
Suppression of hepatic hepcidin expression in response to acute iron deprivation is associated with an increase of matriptase-2 protein. Blood (2010) 1.24
The RGM/DRAGON family of BMP co-receptors. Cytokine Growth Factor Rev (2009) 1.21
Iron regulation by hepcidin. J Clin Invest (2013) 1.21
Regulation of TMPRSS6 by BMP6 and iron in human cells and mice. Blood (2011) 1.19
Tmprss6 is a genetic modifier of the Hfe-hemochromatosis phenotype in mice. Blood (2011) 1.19
Novel association to the proprotein convertase PCSK7 gene locus revealed by analysing soluble transferrin receptor (sTfR) levels. Hum Mol Genet (2010) 1.18
Reduced prostasin (CAP1/PRSS8) activity eliminates HAI-1 and HAI-2 deficiency-associated developmental defects by preventing matriptase activation. PLoS Genet (2012) 1.16
Anemia, ineffective erythropoiesis, and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in β-thalassemia. Hematol Oncol Clin North Am (2010) 1.14
Membrane-anchored serine proteases in health and disease. Prog Mol Biol Transl Sci (2011) 1.13
Iron refractory iron deficiency anemia. Haematologica (2013) 1.13
Iron, anemia and hepcidin in malaria. Front Pharmacol (2014) 1.10
GWAS of blood cell traits identifies novel associated loci and epistatic interactions in Caucasian and African-American children. Hum Mol Genet (2012) 1.09
HRG1 is essential for heme transport from the phagolysosome of macrophages during erythrophagocytosis. Cell Metab (2013) 1.09
Hepcidin modulation in human diseases: from research to clinic. World J Gastroenterol (2009) 1.09
Regulation of type II transmembrane serine proteinase TMPRSS6 by hypoxia-inducible factors: new link between hypoxia signaling and iron homeostasis. J Biol Chem (2010) 1.08
Targeting the hepcidin-ferroportin axis in the diagnosis and treatment of anemias. Adv Hematol (2009) 1.06
An insight into the relationships between hepcidin, anemia, infections and inflammatory cytokines in pediatric refugees: a cross-sectional study. PLoS One (2008) 1.06
β-thalassemias: paradigmatic diseases for scientific discoveries and development of innovative therapies. Haematologica (2015) 1.06
The pathophysiology and pharmacology of hepcidin. Trends Pharmacol Sci (2014) 1.05
Hepcidin antagonists for potential treatments of disorders with hepcidin excess. Front Pharmacol (2014) 1.04
Associations between single nucleotide polymorphisms in iron-related genes and iron status in multiethnic populations. PLoS One (2012) 1.03
Identification of a common variant in the TFR2 gene implicated in the physiological regulation of serum iron levels. Hum Mol Genet (2010) 1.03
Anemia of inflammation. Hematol Oncol Clin North Am (2014) 1.02
Late stage erythroid precursor production is impaired in mice with chronic inflammation. Haematologica (2012) 1.02
Skeletal muscle hemojuvelin is dispensable for systemic iron homeostasis. Blood (2011) 1.02
Iron metabolism: interactions with normal and disordered erythropoiesis. Cold Spring Harb Perspect Med (2012) 1.01
Genome-wide association study identifies genetic loci associated with iron deficiency. PLoS One (2011) 1.01
Severe iron deficiency blunts the response of the iron regulatory gene Hamp and pro-inflammatory cytokines to lipopolysaccharide. Haematologica (2010) 1.01
Applications of high-throughput DNA sequencing to benign hematology. Blood (2013) 1.01
A novel association between a SNP in CYBRD1 and serum ferritin levels in a cohort study of HFE hereditary haemochromatosis. Br J Haematol (2009) 1.00
Hemojuvelin and bone morphogenetic protein (BMP) signaling in iron homeostasis. Front Pharmacol (2014) 1.00
The hepcidin-ferroportin system as a therapeutic target in anemias and iron overload disorders. Hematology Am Soc Hematol Educ Program (2011) 0.99
Control of systemic iron homeostasis by the hemojuvelin-hepcidin axis. Adv Nutr (2010) 0.98
Polymorphisms and mutations of human TMPRSS6 in iron deficiency anemia. Blood Cells Mol Dis (2009) 0.98
Crosstalk between Iron Metabolism and Erythropoiesis. Adv Hematol (2010) 0.98
Neogenin interacts with matriptase-2 to facilitate hemojuvelin cleavage. J Biol Chem (2012) 0.98
Factors influencing disease phenotype and penetrance in HFE haemochromatosis. Hum Genet (2010) 0.97
Iron-deficiency anemia from matriptase-2 inactivation is dependent on the presence of functional Bmp6. Blood (2010) 0.97
Expression and genetic loss of function analysis of the HAT/DESC cluster proteases TMPRSS11A and HAT. PLoS One (2011) 0.96
A novel TMPRSS6 mutation that prevents protease auto-activation causes IRIDA. Biochem J (2010) 0.96
Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C. Gastroenterology (2011) 0.95
Combinatorial effects of malaria season, iron deficiency, and inflammation determine plasma hepcidin concentration in African children. Blood (2014) 0.95
Genome-wide association studies of hematologic phenotypes: a window into human hematopoiesis. Curr Opin Genet Dev (2013) 0.94
Gender-related variations in iron metabolism and liver diseases. World J Hepatol (2010) 0.94
Hepcidin in the diagnosis of iron disorders. Blood (2016) 0.93
Out of balance--systemic iron homeostasis in iron-related disorders. Nutrients (2013) 0.92
A competitive enzyme-linked immunosorbent assay specific for murine hepcidin-1: correlation with hepatic mRNA expression in established and novel models of dysregulated iron homeostasis. Haematologica (2014) 0.92
Genes determining blood cell traits. Nat Genet (2009) 0.92
Iron homeostasis and nutritional iron deficiency. J Nutr (2011) 0.92
Is the iron regulatory hormone hepcidin a risk factor for alcoholic liver disease? World J Gastroenterol (2009) 0.92
Superinfection in malaria: Plasmodium shows its iron will. EMBO Rep (2011) 0.91
High-throughput screening of small molecules identifies hepcidin antagonists. Mol Pharmacol (2013) 0.91
Immunoassay for human serum hemojuvelin. Haematologica (2010) 0.89
Corin mutation R539C from hypertensive patients impairs zymogen activation and generates an inactive alternative ectodomain fragment. J Biol Chem (2013) 0.89
Effect of iron overload and iron deficiency on liver hemojuvelin protein. PLoS One (2012) 0.89
Combination therapy with a Tmprss6 RNAi-therapeutic and the oral iron chelator deferiprone additively diminishes secondary iron overload in a mouse model of β-thalassemia intermedia. Am J Hematol (2015) 0.89
A novel validated enzyme-linked immunosorbent assay to quantify soluble hemojuvelin in mouse serum. Haematologica (2012) 0.88
Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice. Blood (2016) 0.88
Absence of a red blood cell phenotype in mice with hematopoietic deficiency of SEC23B. Mol Cell Biol (2014) 0.88
Hepcidin and ferroportin: the new players in iron metabolism. Semin Liver Dis (2011) 0.88
Four variants in transferrin and HFE genes as potential markers of iron deficiency anaemia risk: an association study in menstruating women. Nutr Metab (Lond) (2011) 0.87
Role of matriptase-2 (TMPRSS6) in iron metabolism. Acta Haematol (2009) 0.87
The erythroid function of transferrin receptor 2 revealed by Tmprss6 inactivation in different models of transferrin receptor 2 knockout mice. Haematologica (2014) 0.87
Hepcidin: regulation of the master iron regulator. Biosci Rep (2015) 0.87
The role of TMPRSS6/matriptase-2 in iron regulation and anemia. Front Pharmacol (2014) 0.87
Role of hepcidin in the pathophysiology and diagnosis of anemia. Blood Res (2013) 0.86
Function of the hemochromatosis protein HFE: Lessons from animal models. World J Gastroenterol (2008) 0.85
Hereditary hemochromatosis and transferrin receptor 2. Biochim Biophys Acta (2011) 0.85
Iron-refractory iron deficiency anemia: new molecular mechanisms. Kidney Int (2009) 0.85
Isocitrate ameliorates anemia by suppressing the erythroid iron restriction response. J Clin Invest (2013) 0.85
Regulation of iron metabolism by hepcidin. Annu Rev Nutr (2006) 3.96
Microcytic anemia with iron malabsorption: an inherited disorder of iron metabolism. Am J Hematol (1996) 2.66
Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications. Clin Chem (2007) 2.41
Matriptase-2, a membrane-bound mosaic serine proteinase predominantly expressed in human liver and showing degrading activity against extracellular matrix proteins. J Biol Chem (2002) 2.31
Ferrokinetics in the syndrome of familial hypoferremic microcytic anemia with iron malabsorption. J Pediatr Hematol Oncol (1999) 1.84
Malabsorption and defective utilization of iron in three siblings. J Pediatr (1981) 1.44
Iron deficiency anemia due to a defect in iron metabolism: a case report. Clin Lab Sci (2001) 1.24
Iron deficiency: lessons from anemic mice. Yale J Biol Med (1998) 1.24
Heme metabolism and in vitro erythropoiesis in anemia associated with hypochromic microcytosis. Am J Hematol (1988) 1.19
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature (2008) 18.20
Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature (2008) 8.69
Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet (2006) 8.32
Balancing acts: molecular control of mammalian iron metabolism. Cell (2004) 7.82
Identifying autism loci and genes by tracing recent shared ancestry. Science (2008) 7.72
A 3.9-centimorgan-resolution human single-nucleotide polymorphism linkage map and screening set. Am J Hum Genet (2003) 5.34
The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab (2005) 5.32
Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood (2010) 4.96
Natural malaria infection in Anopheles gambiae is regulated by a single genomic control region. Science (2006) 4.38
Interleukin-6 induces hepcidin expression through STAT3. Blood (2006) 4.24
Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. J Clin Invest (2007) 4.09
Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways. Diabetes (2010) 4.07
Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood (2002) 3.93
Immortalization and transformation of primary human airway epithelial cells by gene transfer. Oncogene (2002) 3.80
Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells. Nat Genet (2005) 3.28
Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia. N Engl J Med (2014) 3.25
A mouse model of juvenile hemochromatosis. J Clin Invest (2005) 3.25
Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature (2007) 3.06
A cryptic subgroup of Anopheles gambiae is highly susceptible to human malaria parasites. Science (2011) 2.81
Using whole-exome sequencing to identify inherited causes of autism. Neuron (2013) 2.74
Scara5 is a ferritin receptor mediating non-transferrin iron delivery. Dev Cell (2009) 2.60
Deletion of Trpm7 disrupts embryonic development and thymopoiesis without altering Mg2+ homeostasis. Science (2008) 2.59
Definitions of the phenotypic manifestations of sickle cell disease. Am J Hematol (2010) 2.55
Highly penetrant, rapid tumorigenesis through conditional inversion of the tumor suppressor gene Snf5. Cancer Cell (2002) 2.51
Slc11a2 is required for intestinal iron absorption and erythropoiesis but dispensable in placenta and liver. J Clin Invest (2005) 2.45
Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis. Nat Genet (2003) 2.43
Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nat Genet (2003) 2.41
The Steap proteins are metalloreductases. Blood (2006) 2.37
Mutations in mitochondrial carrier family gene SLC25A38 cause nonsyndromic autosomal recessive congenital sideroblastic anemia. Nat Genet (2009) 2.37
The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression. Cell Metab (2008) 2.36
TRP channel regulates EGFR signaling in hair morphogenesis and skin barrier formation. Cell (2010) 2.32
Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease. Ann Intern Med (2008) 2.31
Cdk5rap2 regulates centrosome function and chromosome segregation in neuronal progenitors. Development (2010) 2.31
Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing. J Biol Chem (2006) 2.28
Down-regulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis. Blood (2010) 2.20
Proinflammatory state, hepcidin, and anemia in older persons. Blood (2010) 2.19
Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice. J Clin Invest (2010) 2.18
Genetic loci affecting resistance to human malaria parasites in a West African mosquito vector population. Science (2002) 2.11
Recessive truncating titin gene, TTN, mutations presenting as centronuclear myopathy. Neurology (2013) 2.09
Lymphomas of the breast: primary and secondary involvement. Cancer (2002) 2.06
Glial fibrillary acidic protein as a brain injury biomarker in children undergoing extracorporeal membrane oxygenation. Pediatr Crit Care Med (2011) 2.02
Hematopoietic-specific Stat5-null mice display microcytic hypochromic anemia associated with reduced transferrin receptor gene expression. Blood (2008) 2.01
Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation. Blood (2007) 1.97
Haem homeostasis is regulated by the conserved and concerted functions of HRG-1 proteins. Nature (2008) 1.95
An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia. Blood (2012) 1.94
Design of the silent cerebral infarct transfusion (SIT) trial. Pediatr Hematol Oncol (2010) 1.87
Endogenous oncogenic Nras mutation promotes aberrant GM-CSF signaling in granulocytic/monocytic precursors in a murine model of chronic myelomonocytic leukemia. Blood (2010) 1.86
T-lymphoblastic lymphoma cells express high levels of BCL2, S1P1, and ICAM1, leading to a blockade of tumor cell intravasation. Cancer Cell (2010) 1.85
A systematic review of barriers and interventions to improve appropriate use of therapies for sickle cell disease. J Natl Med Assoc (2009) 1.70
An Hfe-dependent pathway mediates hyposideremia in response to lipopolysaccharide-induced inflammation in mice. Nat Genet (2004) 1.68
Anemia of inflammation: the hepcidin link. Curr Opin Hematol (2005) 1.65
Anticoagulation monitoring during pediatric extracorporeal membrane oxygenation. ASAIO J (2012) 1.65
Erythropoietin stimulates phosphorylation and activation of GATA-1 via the PI3-kinase/AKT signaling pathway. Blood (2005) 1.63
Perturbation of hepcidin expression by BMP type I receptor deletion induces iron overload in mice. Blood (2011) 1.49
The mitochondrial ATP-binding cassette transporter Abcb7 is essential in mice and participates in cytosolic iron-sulfur cluster biogenesis. Hum Mol Genet (2006) 1.47
Iron is essential for neuron development and memory function in mouse hippocampus. J Nutr (2009) 1.47
Long-term safety and efficacy of deferasirox (Exjade) for up to 5 years in transfusional iron-overloaded patients with sickle cell disease. Br J Haematol (2011) 1.45
Iron-responsive degradation of iron-regulatory protein 1 does not require the Fe-S cluster. EMBO J (2006) 1.43
Systematic molecular genetic analysis of congenital sideroblastic anemia: evidence for genetic heterogeneity and identification of novel mutations. Pediatr Blood Cancer (2010) 1.43
Transferrin is a major determinant of hepcidin expression in hypotransferrinemic mice. Blood (2010) 1.41
X-linked gray platelet syndrome due to a GATA1 Arg216Gln mutation. Blood (2007) 1.38
nm1054: a spontaneous, recessive, hypochromic, microcytic anemia mutation in the mouse. Blood (2005) 1.38
Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure. Blood (2011) 1.37
Failure of red blood cell maturation in mice with defects in the high-density lipoprotein receptor SR-BI. Blood (2002) 1.37
Probucol prevents early coronary heart disease and death in the high-density lipoprotein receptor SR-BI/apolipoprotein E double knockout mouse. Proc Natl Acad Sci U S A (2003) 1.33
The channel kinase, TRPM7, is required for early embryonic development. Proc Natl Acad Sci U S A (2011) 1.29
Abcb7, the gene responsible for X-linked sideroblastic anemia with ataxia, is essential for hematopoiesis. Blood (2006) 1.28
Heme-regulated eIF2alpha kinase modifies the phenotypic severity of murine models of erythropoietic protoporphyria and beta-thalassemia. J Clin Invest (2005) 1.26
Iron homeostasis and erythropoiesis. Curr Top Dev Biol (2008) 1.26
Primary ciliary dyskinesia in mice lacking the novel ciliary protein Pcdp1. Mol Cell Biol (2007) 1.26
A spontaneous, recurrent mutation in divalent metal transporter-1 exposes a calcium entry pathway. PLoS Biol (2004) 1.26
AKT induces erythroid-cell maturation of JAK2-deficient fetal liver progenitor cells and is required for Epo regulation of erythroid-cell differentiation. Blood (2005) 1.25
SOD2-deficiency anemia: protein oxidation and altered protein expression reveal targets of damage, stress response, and antioxidant responsiveness. Blood (2004) 1.23
Genetic variation in Mon1a affects protein trafficking and modifies macrophage iron loading in mice. Nat Genet (2007) 1.23
Parent education and biologic factors influence on cognition in sickle cell anemia. Am J Hematol (2014) 1.22
Tmprss6 is a genetic modifier of the Hfe-hemochromatosis phenotype in mice. Blood (2011) 1.19
Chronic hepcidin induction causes hyposideremia and alters the pattern of cellular iron accumulation in hemochromatotic mice. Blood (2005) 1.18
Leptospirosis as frequent cause of acute febrile illness in southern Sri Lanka. Emerg Infect Dis (2011) 1.17
A mutation in Sec15l1 causes anemia in hemoglobin deficit (hbd) mice. Nat Genet (2005) 1.16
Cybrd1 (duodenal cytochrome b) is not necessary for dietary iron absorption in mice. Blood (2005) 1.16